Hangzhou Go Top Peptide Biotech Co., Ltd. is a peptide manufacturer based in China. Direct manufacturer. Founded 2014. Holds US DMFs for semaglutide API.
Listing reviewed September 2026.
Chinese national high-tech enterprise established in 2014, specializing in R&D and manufacturing of peptides and related derivatives. Operates a 4,000 sqm peptide research center in Hangzhou with multiple complete peptide production lines, large-scale synthesizers, and clean laboratories it describes as GMP-standard. ISO 9001:2015 certified quality management system. cGMP-compliant manufacturing facility in Shaoxing covers 33,000 sqm with annual capacity of approximately 2,500 kg Tirzepatide and 2,500 kg Semaglutide. Provides integrated peptide services from R&D to commercial production for global pharmaceutical, cosmetic, and biotech partners.
Directory assessment: Hangzhou Go Top Peptide Biotech Co., Ltd. is listed as a manufacturer in the peptide supply chain, serving Asia markets from China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 2 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.
DMF numbers from the FDA quarterly DMF list. A filed DMF is not FDA approval; its contents are confidential. Reviewed 2026-10-15.